In its decision to approve two drugs for orange and grapefruit trees, the E.P.A. largely ignored objections from the C.D.C. and the F.D.A., which fear that expanding their use in cash crops could fuel antibiotic resistance in humans.
The New York Times
By ANDREW JACOBS and MICHAEL ADNO from NYT Health https://nyti.ms/2HqdjH5
May 16, 2019 at 02:00PM
No comments:
Post a Comment